Picture of Biotech Growth Trust logo

BIOG Biotech Growth Trust Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
FinancialsBalancedMid Cap

Annual cashflow statement for Biotech Growth Trust, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.

2018
March 31st
2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-29.521.361.1201-202
Non-Cash Items26.2-24.6-64.1-224209
Other Non-Cash Items
Changes in Working Capital-0.717-1.09-0.79818.1-18.4
Change in Accounts Receivable
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities-4.11-4.4-3.77-5.67-12.1
Other Investing Cash Flow Items-7.8145.890.9-25.513
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-7.8145.890.9-25.513
Financing Cash Flow Items-0.25-0.179
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities25-41.4-87.232.7-2.39
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash13.1001.5-1.5

Or unlock with your email

Or unlock with your email